Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

San Diego, USA
P.O. Box 262309
San Diego, CA, 92196-2309
USA

People

President & CEO
Board
Executive VP of Research & CSO

Funding

TOTAL $5.95M
FUNDING TOTAL $5.95M
Series A, 5/2010
$2.78M
Venture Round, 11/2011
$3.17M

Tags

iTherX

iTherX is a clinical stage pharmaceutical company focused on the discovery and development of innovative treatments for Hepatitis C. This is a disease that affects almost 3% of the world’s population, and is the major cause of chronic liver disease, cirrhosis, liver failure and primary liver cancer. Currently there is only a single mode of therapy and less than 5% of patients can be successfully treated.

Recent Milestones

Videos

Screenshots

iTherX screenshot
Above: iTherX
Uploaded: 2/23/13

Sources

  1. SEC (sec.gov) [edit]
  2. SEC (sec.gov) [edit]
Edit This Page
Last Edited 12/9/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy